Pre-validation study of alternative developmental toxicity test using mouse embryonic stem cell-derived embryoid...

Area of Science:

• Developmental toxicology
• Alternative testing methods

Background:

• The embryoid body test (EBT) assesses chemical toxicity using embryoid bodies (EBs) and mouse embryonic stem cells (ESCs).
• EBT offers advantages over the embryonic stem cell test (EST) by reducing time, labor, and material requirements.
• Previous studies indicated EBT's potential for improved classification of embryotoxic potential.

Purpose of the Study:

• To evaluate the predictive accuracy and reproducibility of the EBT.
• To validate EBT as a reliable method for developmental toxicity testing.
• To assess EBT's performance across intra-laboratory and inter-laboratory settings.

Main Methods:

• Utilized 26 coded substances for pre-validation testing.
• Conducted intra-laboratory and inter-laboratory reproducibility tests.
• Employed a new prediction model classifying substances into non-toxic and toxic categories.

Main Results:

• The EBT demonstrated high accuracy (above 80%) in classifying substances using the predictive model.
• Both intra-laboratory and inter-laboratory tests confirmed the EBT's reliability.
• The simplified classification model effectively categorized embryotoxic potential.

Conclusions:

• The embryoid body test (EBT) is a validated and accurate method for classifying embryotoxicants.
• EBT provides a rapid and efficient approach to developmental toxicity testing.
• The test method requires less effort and offers greater validation compared to existing alternatives.